Literature DB >> 29286428

Stenosis of the Inferior Vena Cava: A Murine Model of Deep Vein Thrombosis.

Holly Payne1, Alexander Brill2.   

Abstract

Deep vein thrombosis (DVT) and its devastating complication, pulmonary embolism, are a severe health problem with high mortality. Mechanisms of thrombus formation in veins remain obscure. Lack of mobility (e.g., after surgery or long-haul flights) is one of the main factors leading to DVT. The pathophysiological consequence of the lack of mobility is blood flow stagnation in venous valves. Here, a model is described that mimics such flow disturbance as a thrombosis-driving factor. In this model, partial flow restriction (stenosis) in the inferior vena cava (IVC) is created. Closure of about 90% of the IVC lumen for 48 h results in development of thrombi structurally similar to those in humans. The similarities are: i) most of the thrombus volume is red, i.e., consists of red blood cells and fibrin, ii) presence of a white part (lines of Zahn), iii) non-denuded endothelial monolayer, iv) elevated plasma D-Dimer levels, and v) possibility to prevent thrombosis by low molecular weight heparin. Limitations include variable size of thrombi and the fact that a certain percentage of wild-type mice (0 - 35%) may not produce a thrombus. In addition to visual observation and measurement, thrombi may be visualized by non-invasive technologies, such as ultrasonography, which allows for monitoring the dynamics of thrombus development. At shorter time points (1 - 6 h), intravital microscopy may be applied to directly observe events (e.g., recruitment of cells to the vessel wall) preceding thrombus formation. Use of this method by several teams around the world has made it possible to uncover basic mechanisms of DVT initiation and identify potential targets that might be beneficial for its prevention.

Entities:  

Mesh:

Year:  2017        PMID: 29286428      PMCID: PMC5755672          DOI: 10.3791/56697

Source DB:  PubMed          Journal:  J Vis Exp        ISSN: 1940-087X            Impact factor:   1.355


  26 in total

1.  Persistence of platelet thrombus formation in arterioles of mice lacking both von Willebrand factor and fibrinogen.

Authors:  H Ni; C V Denis; S Subbarao; J L Degen; T N Sato; R O Hynes; D D Wagner
Journal:  J Clin Invest       Date:  2000-08       Impact factor: 14.808

Review 2.  Travel and venous thrombosis: a systematic review.

Authors:  S Kuipers; A J M Schreijer; S C Cannegieter; H R Büller; F R Rosendaal; S Middeldorp
Journal:  J Intern Med       Date:  2007-12       Impact factor: 8.989

Review 3.  Crossroads of coagulation and innate immunity: the case of deep vein thrombosis.

Authors:  C Schulz; B Engelmann; S Massberg
Journal:  J Thromb Haemost       Date:  2013-06       Impact factor: 5.824

4.  Comparison of the effect of dabigatran and dalteparin on thrombus stability in a murine model of venous thromboembolism.

Authors:  S A Shaya; L J Saldanha; N Vaezzadeh; J Zhou; R Ni; P L Gross
Journal:  J Thromb Haemost       Date:  2016-01-04       Impact factor: 5.824

5.  Enhanced venous thrombus resolution in plasminogen activator inhibitor type-2 deficient mice.

Authors:  S A Siefert; C Chabasse; S Mukhopadhyay; M H Hoofnagle; D K Strickland; R Sarkar; T M Antalis
Journal:  J Thromb Haemost       Date:  2014-09-30       Impact factor: 5.824

6.  Neutrophil extracellular traps promote deep vein thrombosis in mice.

Authors:  A Brill; T A Fuchs; A S Savchenko; G M Thomas; K Martinod; S F De Meyer; A A Bhandari; Denisa D Wagner
Journal:  J Thromb Haemost       Date:  2012-01       Impact factor: 5.824

7.  Secular trends in occurrence of acute venous thromboembolism: the Worcester VTE study (1985-2009).

Authors:  Wei Huang; Robert J Goldberg; Frederick A Anderson; Catarina I Kiefe; Frederick A Spencer
Journal:  Am J Med       Date:  2014-05-06       Impact factor: 4.965

8.  Macrovascular thrombosis is driven by tissue factor derived primarily from the blood vessel wall.

Authors:  Sharlene M Day; Jennifer L Reeve; Brian Pedersen; Diana M Farris; Daniel D Myers; Michael Im; Thomas W Wakefield; Nigel Mackman; William P Fay
Journal:  Blood       Date:  2004-08-31       Impact factor: 22.113

9.  Mice with a deficiency in CLEC-2 are protected against deep vein thrombosis.

Authors:  Holly Payne; Tatyana Ponomaryov; Steve P Watson; Alexander Brill
Journal:  Blood       Date:  2017-01-19       Impact factor: 22.113

10.  Monocytes, neutrophils, and platelets cooperate to initiate and propagate venous thrombosis in mice in vivo.

Authors:  Marie-Luise von Brühl; Konstantin Stark; Alexander Steinhart; Sue Chandraratne; Ildiko Konrad; Michael Lorenz; Alexander Khandoga; Anca Tirniceriu; Raffaele Coletti; Maria Köllnberger; Robert A Byrne; Iina Laitinen; Axel Walch; Alexander Brill; Susanne Pfeiler; Davit Manukyan; Siegmund Braun; Philipp Lange; Julia Riegger; Jerry Ware; Annekathrin Eckart; Selgai Haidari; Martina Rudelius; Christian Schulz; Katrin Echtler; Volker Brinkmann; Markus Schwaiger; Klaus T Preissner; Denisa D Wagner; Nigel Mackman; Bernd Engelmann; Steffen Massberg
Journal:  J Exp Med       Date:  2012-03-26       Impact factor: 14.307

View more
  10 in total

1.  Effects of clot contraction on clot degradation: A mathematical and experimental approach.

Authors:  Rebecca A Risman; Ahmed Abdelhamid; John W Weisel; Brittany E Bannish; Valerie Tutwiler
Journal:  Biophys J       Date:  2022-08-03       Impact factor: 3.699

2.  An in situ inferior vena cava ligation-stenosis model to study thrombin generation rates with flow.

Authors:  Wei Yin; Andrew Dimatteo; Andrew Kumpfbeck; Stephen Leung; Marina Fandaros; Bryan Musmacker; David A Rubenstein; Mary D Frame
Journal:  Thromb J       Date:  2022-05-25

3.  Cellular fibronectin promotes deep vein thrombosis in diet-induced obese mice.

Authors:  Nirav Dhanesha; Manish Jain; Prakash Doddapattar; Anetta Undas; Anil K Chauhan
Journal:  J Thromb Haemost       Date:  2020-12-27       Impact factor: 5.824

Review 4.  Fibrinolysis and Inflammation in Venous Thrombus Resolution.

Authors:  Subhradip Mukhopadhyay; Tierra A Johnson; Nadire Duru; Marguerite S Buzza; Nisha R Pawar; Rajabrata Sarkar; Toni M Antalis
Journal:  Front Immunol       Date:  2019-06-14       Impact factor: 7.561

5.  IL-1β Blockade Attenuates Thrombosis in a Neutrophil Extracellular Trap-Dependent Breast Cancer Model.

Authors:  Tainá Gomes; Carolina B S Várady; André L Lourenço; Daniella M Mizurini; Araci M R Rondon; Ana C Leal; Barbara S Gonçalves; Dumith Chequer Bou-Habib; Emiliano Medei; Robson Q Monteiro
Journal:  Front Immunol       Date:  2019-09-04       Impact factor: 7.561

6.  Multiple Facets of Venous Thrombosis.

Authors:  Alexander Brill
Journal:  Int J Mol Sci       Date:  2021-04-08       Impact factor: 6.208

7.  Establishment of a Modified and Standardized Ferric Chloride-Induced Rat Carotid Artery Thrombosis Model.

Authors:  Xiao Lin; Peiqi Zhao; Zhongxiao Lin; Jiayu Chen; Lebohang Anesu Bingwa; Felix Siaw-Debrah; Peng Zhang; Kunlin Jin; Su Yang; Qichuan Zhuge
Journal:  ACS Omega       Date:  2022-03-02

8.  The role of valve stiffness in the insurgence of deep vein thrombosis.

Authors:  Zoe Schofield; Hosam Alden Baksamawi; Joana Campos; Alessio Alexiadis; Gerard B Nash; Alexander Brill; Daniele Vigolo
Journal:  Commun Mater       Date:  2020-09-16

Review 9.  Understanding the Pathophysiology of Thrombotic APS through Animal Models.

Authors:  Alex A Gandhi; Shanea K Estes; Christine E Rysenga; Jason S Knight
Journal:  Int J Mol Sci       Date:  2021-03-04       Impact factor: 5.923

Review 10.  Immune Factors in Deep Vein Thrombosis Initiation.

Authors:  Ivan Budnik; Alexander Brill
Journal:  Trends Immunol       Date:  2018-05-16       Impact factor: 16.687

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.